← Leaderboards
Alexei G Basnakian
Central Arkansas Veterans Hlthcare Sys
$3,611,011
Attributed
$3,611,011
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $596.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,611,011 · 6
VA$0 · 3
By mechanism
R01$1,499,048 · 1
P20$1,027,993 · 1
P30$596,700 · 1
R21$362,750 · 1
R03$124,520 · 1
P01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Central Arkansas Veterans Hlthcare Sys
Same institution · by research overlap
- Jeffrey M. Pyne$1,624,634
Others in their field
Top investigators on “Injury”
- Polly Chang · Sri International$119,352,977
- Marco Pahor · Wake Forest University Health Sciences$82,312,292
- Kerry J Kelly · New York City Fire Department$81,924,266
- Asrar B. Malik · University Of Illinois At Chicago$81,164,529
- Peter Scott Heeger · Case Western Reserve University$76,259,223
- Jacqueline Moline · Icahn School Of Medicine At Mount Sinai$75,762,106
Research focus
InjuryCell InjuryKidneyDna FragmentationCell DeathIn VitroAffectDeoxyribonuclease IMediatingIn VivoCellsAcuteTubular FormationEndonucleaseEnzymesApoptoticAcute Renal Failure With Renal Papillary NecrosisDeoxyribonucleasesPharmaceutical PreparationsReportingEpitheliumEndonuclease GKidney CellEpithelial Cells
Grant awards (33)
Admin Core$596,700
P30 · FY2025 · GM · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Nuclease mechanisms in acute kidney injury$0
I01 · FY2024 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
Cellular and Molecular Toxicology Core$258,400
P20 · FY2023 · GM · contact PI
DNase-Targeted Mitigation of Acute Kidney Injury Due to Rhabdomyolysis$0
I01 · FY2023 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
Cellular and Molecular Toxicology Core$252,793
P20 · FY2022 · GM · contact PI
DNase-Targeted Mitigation of Acute Kidney Injury Due to Rhabdomyolysis$0
I01 · FY2022 · VA · contact PI
Cellular and Molecular Toxicology Core$258,400
P20 · FY2021 · GM · contact PI
DNase-Targeted Mitigation of Acute Kidney Injury Due to Rhabdomyolysis$0
I01 · FY2021 · VA · contact PI
Cellular and Molecular Toxicology Core$258,400
P20 · FY2020 · GM · contact PI
DNase-Targeted Mitigation of Acute Kidney Injury Due to Rhabdomyolysis$0
I01 · FY2020 · VA · contact PI
New mechanistic therapies for myoglobinuric acute kidney injury$0
I01 · FY2018 · VA · contact PI
New mechanistic therapies for myoglobinuric acute kidney injury$0
I01 · FY2017 · VA · contact PI
New mechanistic therapies for myoglobinuric acute kidney injury$0
I01 · FY2016 · VA · contact PI
New mechanistic therapies for myoglobinuric acute kidney injury$0
I01 · FY2015 · VA · contact PI
Novel endonuclease-targeted approaches to nephroprotection$0
I01 · FY2013 · VA · contact PI
Premortem enzymatic DNA damage in kidney injury$284,229
R01 · FY2012 · DK · contact PI
Novel endonuclease-targeted approaches to nephroprotection$0
I01 · FY2012 · VA · contact PI
Premortem enzymatic DNA damage in kidney injury$284,229
R01 · FY2011 · DK · contact PI
Novel endonuclease-targeted approaches to nephroprotection$0
I01 · FY2011 · VA · contact PI
Premortem enzymatic DNA damage in kidney injury$287,100
R01 · FY2010 · DK · contact PI
Premortem enzymatic DNA damage in kidney injury$63,990
R01 · FY2010 · DK · contact PI
Premortem enzymatic DNA damage in kidney injury$290,000
R01 · FY2009 · DK · contact PI
LDL isoforms in kidney-related atherosclerosisv$156,500
R21 · FY2009 · HL · contact PI
Novel endonuclease-targeted approaches to nephroprotection$0
I01 · FY2009 · VA · contact PI
Premortem enzymatic DNA damage in kidney injury$289,500
R01 · FY2008 · DK · contact PI
LDL isoforms in kidney-related atherosclerosisv$206,250
R21 · FY2008 · HL · contact PI
Endonuclease dificiency in breast cancer progression$61,520
R03 · FY2006 · CA · contact PI
Endonuclease deficiency in breast cancer progression$63,000
R03 · FY2005 · CA
Regulation of DNase I During Ischemic Renal Injury$0
P01 · FY2002 · DK
Regulation of DNase I During Ischemic Renal Injury$0
P01 · FY2001 · DK